Nature Reviews Disease Primers (2018) https://doi.org/10.1038/s41572-018-0014-7 Published online 16 August 2018
The originally published article contained an error in figure 8 part a, in which cut off values for F3 fibrosis, cirrhosis, and screening for oesophageal varices and HCC were incorrectly presented as <8 kPa, <12.5 kPa and <20 kPa, respectively. These cut off values have been corrected in the HTML and PDF versions of the manuscript to >8 kPa for F3 fibrosis, >12.5 kPa for cirrhosis and >20 kPa for screening for oesophageal varices and HCC.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seitz, H.K., Bataller, R., Cortez-Pinto, H. et al. Publisher Correction: Alcoholic liver disease. Nat Rev Dis Primers 4, 18 (2018). https://doi.org/10.1038/s41572-018-0021-8
Published:
DOI: https://doi.org/10.1038/s41572-018-0021-8
This article is cited by
-
Downregulating PDPK1 and taking phillyrin as PDPK1-targeting drug protect hepatocytes from alcoholic steatohepatitis by promoting autophagy
Cell Death & Disease (2022)
-
Second-harmonic generation (SHG) microscopy and hepatic venous pressure gradient-based validation of a novel histological staging system for alcoholic hepatitis
Virchows Archiv (2021)
-
Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids
European Journal of Nutrition (2020)
